Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Златослава Алексеевна Шаенко, Михаил Сахнович Расин, Игорь Петрович Кайдашев, Алексей Викторович Лигоненко, Илья Иванович ДегтярьfiledCriticalЗлатослава Алексеевна Шаенко
Priority to UAU201303314UpriorityCriticalpatent/UA83145U/en
Publication of UA83145UpublicationCriticalpatent/UA83145U/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
A method for the rational complex therapy of the patients with ischemic heart disease and diabetes mellitus type 2 comprises the use of the inhibitors of angiotensin-conversion enzyme, the blockers of angiotensin receptors, beta-blockers, diuiretics, aldosterone antagonists, blockers of calcium canals. In addition, Metformin and Pioglitazone are used at the therapeutic doses for three months.
UAU201303314U2013-03-182013-03-18Method for rational complex therapy of patients with ischemic heart disease and diabetes mellitus type 2
UA83145U
(en)
Use of dronedarone or one of its pharmaceutically acceptable salts for preparing a medicament for the treatment of patients with arrhythmia and an increased creatinine level due to dronedarone administration
SOLID ORAL DOSAGE FORM THAT INCLUDES ALISQUIRENE, HYDROCLOROTIAZIDA AND A HYDROPHILIC FILLING; PREPARATION PROCESS; AND USE IN THE TREATMENT OF SUCH DISEASES AS HYPERTENSION, CONGESTIVE CARDIAC INSUFFICIENCY, MYOCARDIUM INFAR,